First-in-human phase I trial to assess the efficacy and safety of a novel Myc inhibitor
Peptomyc's Omomyc-based therapy against cancer put to the clinical testCredit: VHIO Co-founded back in 2014 by VHIO's Laura Soucek, CEO of the enterprise, and Marie-Eve...
















